GlassScriptPhysician profile
Varun Laohaprasit
NPI 1629172929
$866.11
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $408 · 2021: $43.29.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $132.65 | 2019-2020 | |
| Greenwich Biosciences, INC. | $93.97 | 2019 | |
| Emd Serono, INC. | $79.11 | 2020-2021 | |
| Nuvasive, INC. | $55.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $53.25 | 2019-2020 | |
| Genzyme Corporation | $38.94 | 2020 | |
| Biogen, INC. | $38.93 | 2020 | |
| Nevro Corp. | $38.50 | 2019 | |
| Boston Scientific Corporation | $37.94 | 2019-2020 | |
| Assertio Therapeutics, INC. | $35.55 | 2020 | |
| Supernus Pharmaceuticals, INC. | $34.99 | 2019 | |
| Lilly USA, LLC | $29.66 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $25.21 | 2020 | |
| Amgen INC. | $22.46 | 2019 | |
| Csl Behring | $21.72 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $19.93 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $18.03 | 2021 | |
| Ethicon US, LLC | $18.03 | 2020 | |
| Amneal Pharmaceuticals LLC | $16.06 | 2019 | |
| Neurelis, INC. | $15.67 | 2020 | |
| Arbor Pharmaceuticals, INC. | $14.40 | 2019 | |
| Globus Medical, INC. | $14.25 | 2019 | |
| Bausch Health US, LLC | $11.69 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varun Laohaprasit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.